Search Results

Filter
  • 1-10 of  6,225 results for ""Aspirin""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Aspirin for the Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.

  • Authors : Shufelt CL; Barbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.; now with Mayo Clinic Women's Health and Division of General Internal Medicine, Jacksonville, Florida.

Subjects: Aspirin*/Aspirin*/Aspirin*/therapeutic use ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control ; Platelet Aggregation Inhibitors*/Platelet Aggregation Inhibitors*/Platelet Aggregation Inhibitors*/therapeutic use

  • Source: JAMA [JAMA] 2022 Aug 16; Vol. 328 (7), pp. 672-673.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events.

  • Authors : Calderone D; Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico 'G. Rodolico-San Marco' University of Catania, Catania, Italy.; Ingala S

Subjects: Aspirin*/Aspirin*/Aspirin*/adverse effects ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control; Hemorrhage/Hemorrhage/Hemorrhage/chemically induced

  • Source: Expert review of cardiovascular therapy [Expert Rev Cardiovasc Ther] 2021 Dec; Vol. 19 (12), pp. 1097-1117. Date of Electronic Publication: 2021 Dec 29.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101182328 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Aspirin dosing for atherosclerotic cardiovascular disease: should we be more ADAPTABLE?

  • Authors : Parker WAE; Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK.; Department of Cardiology, South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Subjects: Aspirin/Aspirin/Aspirin/*administration & dosage ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*drug therapy ; Blood Platelets/Blood Platelets/Blood Platelets/*drug effects

  • Source: Cardiovascular research [Cardiovasc Res] 2021 Aug 29; Vol. 117 (10), pp. e123-e125.Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245

Record details

×
Academic Journal

Would You Recommend Aspirin to This Patient for Primary Prevention of Atherosclerotic Cardiovascular Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

  • Authors : Burns RB; Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts (R.B.B., Z.K.).; Pignone M

Subjects: Aspirin/Aspirin/Aspirin/*therapeutic use ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*prevention & control ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control

  • Source: Annals of internal medicine [Ann Intern Med] 2021 Oct; Vol. 174 (10), pp. 1439-1446. Date of Electronic Publication: 2021 Oct 12.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

×
Academic Journal

The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach.

  • Authors : Fras Z; Division of Medicine, Department of Vascular Medicine, Centre for Preventive Cardiology, University Medical Centre Ljubljana, Zaloška 7, 1525, Ljubljana, Slovenia. .; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia. .

Subjects: Aspirin/Aspirin/Aspirin/*administration & dosage ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*prevention & control ; Primary Prevention/Primary Prevention/Primary Prevention/*methods

  • Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2021 Mar; Vol. 21 (2), pp. 139-151.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial.

Subjects: Aspirin/Aspirin/Aspirin/*administration & dosage ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*prevention & control ; Ethics Committees, Research/Ethics Committees, Research/Ethics Committees, Research/*standards

  • Source: Trials [Trials] 2021 Jan 25; Vol. 22 (1), pp. 90. Date of Electronic Publication: 2021 Jan 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

×
Editorial & Opinion

Aspirin for primary prevention.

  • Authors : Henning E; Cincinnati Veterans Affairs Medical Center and University of Cincinnati, Cincinnati, OH.

Subjects: Aspirin* ; Atherosclerosis*; Humans

  • Source: Cleveland Clinic journal of medicine [Cleve Clin J Med] 2020 Jul 31; Vol. 87 (8), pp. 458. Date of Electronic Publication: 2020 Jul 31.Publisher: Cleveland Clinic Educational Foundation Country of Publication: United States NLM ID: 8703441 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease.

  • Authors : Ajufo E; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.; Ayers CR

Subjects: Aspirin/Aspirin/Aspirin/*therapeutic use ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*prevention & control ; Coronary Artery Disease/Coronary Artery Disease/Coronary Artery Disease/*diagnostic imaging

  • Source: JAMA cardiology [JAMA Cardiol] 2021 Feb 01; Vol. 6 (2), pp. 179-187.Publisher: American Medical Association Country of Publication: United States NLM ID: 101676033 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.

Subjects: Aspirin/Aspirin/Aspirin/*therapeutic use ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*drug therapy ; Cerebrovascular Disorders/Cerebrovascular Disorders/Cerebrovascular Disorders/*drug therapy

  • Source: Stroke [Stroke] 2020 Dec; Vol. 51 (12), pp. 3504-3513. Date of Electronic Publication: 2020 Nov 16.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0235266 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Aspirin for Primary Prevention of Cardiovascular Disease.

  • Authors : Kheiri B; Department of Internal Medicine, Hurley Medical Center/Michigan State University, Flint, MI (B.K., M.B., G.B.).; Barbarawi M

Subjects: Primary Prevention*; Aspirin/Aspirin/Aspirin/*therapeutic use ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*prevention & control

  • Source: Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2019 Jun; Vol. 12 (6), pp. e005846. Date of Electronic Publication: 2019 Jun 05.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101489148 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  6,225 results for ""Aspirin""